Author Correction: Transcriptional network analysis implicates altered hepatic immune function in NASH development and resolution.

Journal

Nature metabolism
ISSN: 2522-5812
Titre abrégé: Nat Metab
Pays: Germany
ID NLM: 101736592

Informations de publication

Date de publication:
Jul 2019
Historique:
entrez: 23 7 2020
pubmed: 23 7 2020
medline: 23 7 2020
Statut: ppublish

Résumé

In the version of this article initially published, ANR grant ANR-16-RHUS-0006 to author Joel T. Haas was not included in the Acknowledgements. The error has been corrected in the HTML and PDF versions of the article.

Identifiants

DOI: 10.1038/s42255-019-0093-0 PMID: 32694642
pubmed: 32694642
doi: 10.1038/s42255-019-0093-0
pii: 10.1038/s42255-019-0093-0
doi:

Types de publication

Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

744

Commentaires et corrections

Type : ErratumFor

Auteurs

Joel T Haas (JT)

University of Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France.
ORCID: 0000-0002-0028-5988

Luisa Vonghia (L)

Department of Gastroenterology and Hepatology, Antwerp University Hospital, Antwerp, Belgium. luisa.vonghia@uza.be.
Laboratory of Experimental Medicine and Paediatrics, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium. luisa.vonghia@uza.be.
ORCID: 0000-0002-3999-9259

Denis A Mogilenko (DA)

University of Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France.
ORCID: 0000-0001-5427-5243

An Verrijken (A)

Laboratory of Experimental Medicine and Paediatrics, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
Department of Endocrinology, Diabetology and Metabolism, Antwerp University Hospital, University of Antwerp, Antwerp, Belgium.

Olivier Molendi-Coste (O)

University of Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France.

Sébastien Fleury (S)

University of Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France.

Audrey Deprince (A)

University of Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France.

Artemii Nikitin (A)

University of Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France.

Eloïse Woitrain (E)

University of Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France.

Lucie Ducrocq-Geoffroy (L)

University of Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France.

Samuel Pic (S)

University of Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France.

Bruno Derudas (B)

University of Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France.

Hélène Dehondt (H)

University of Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France.

Céline Gheeraert (C)

University of Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France.

Luc Van Gaal (L)

Laboratory of Experimental Medicine and Paediatrics, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
Department of Endocrinology, Diabetology and Metabolism, Antwerp University Hospital, University of Antwerp, Antwerp, Belgium.

Ann Driessen (A)

Department of Pathology, Antwerp University Hospital, University of Antwerp, Antwerp, Belgium.

Philippe Lefebvre (P)

University of Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France.
ORCID: 0000-0002-9366-5129

Bart Staels (B)

University of Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France.

Sven Francque (S)

Department of Gastroenterology and Hepatology, Antwerp University Hospital, Antwerp, Belgium.
Laboratory of Experimental Medicine and Paediatrics, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
ORCID: 0000-0002-7527-4714

David Dombrowicz (D)

University of Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France. david.dombrowicz@pasteur-lille.fr.

Classifications MeSH